TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21143588

Group type: EXPERIMENTAL
Intervention: Written information brochure on improving vitamin D status in native language
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care (oral information only)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison of intervention and control groups
Number of subjects: 44
Study: 19041012

Group type: EXPERIMENTAL
Intervention: Minimally invasive thyroid surgery (MITS) through a lateral 2.5-cm incision
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional hemithyroidectomy (CHT) through a traditional 5- to 6-cm cervicotomy
Number of subjects: 100
Study: 16433875

Group type: EXPERIMENTAL
Intervention: ACIDFORM gel (5 g, intravaginally once daily for five consecutive days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metronidazole gel (10%, intravaginally once daily for five consecutive days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ACIDFORM gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metronidazole gel
Number of subjects: 30
Study: 14506625

Group type: EXPERIMENTAL
Intervention: recombinant human IGF-I (15 microg/kg body weight/d twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 10981173

Group type: EXPERIMENTAL
Intervention: Low-dose spironolactone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective aldosterone antagonists
Number of subjects: 0
Study: 9298392

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Small‐incision cholecystectomy
Number of subjects: 200
Study: 8509754

Group type: EXPERIMENTAL
Intervention: 4% prilocaine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 3% mepivacaine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2% lidocaine (1:100,000 epinephrine)
Number of subjects: 30
Study: 3119520

Group type: EXPERIMENTAL
Intervention: Cost sharing
Number of subjects: 3565

Group type: COMPARATOR
Intervention: Free care
Number of subjects: 3565
Study: 29035687

Group type: EXPERIMENTAL
Intervention: Glutamine (GLN)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 13
Study: 27542384

Group type: EXPERIMENTAL
Intervention: Free fruit at work intervention for 18 weeks
Number of subjects: 23
Study: 25080462

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant human growth hormone (rhGH) (0.05 mg · kg⁻¹ · d⁻¹)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 22722511

Group type: EXPERIMENTAL
Intervention: Oxygen-enriched air inhalation (normobaric hyperoxia of 40% fraction of inspired oxygen)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular air inhalation (21% fraction of inspired oxygen)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oxygen-enriched air inhalation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Regular air inhalation
Number of subjects: 20
Study: 20398563

Group type: EXPERIMENTAL
Intervention: L-carnitine (5 g/d intravenously for seven days)
Number of subjects: 66
Study: 18779465

Group type: EXPERIMENTAL
Intervention: DM-specific personal health record (PHR) that imported clinical and medications data, provided patient-tailored decision support, and enabled the patient to author a 'Diabetes Care Plan' for electronic submission to their physician.
Number of subjects: 244

Group type: COMPARATOR
Intervention: Active control PHR to update and submit family history and health maintenance information.
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Both intervention and control groups after 1 year.
Number of subjects: 244
Study: 15625373

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Carboplatin-paclitaxel combination
Number of subjects: 561

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy in performance status 2 patients
Number of subjects: 561
Study: 12027065

Group type: EXPERIMENTAL
Intervention: Fexofenadine (60 mg, twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal antigen challenge
Number of subjects: 0
Study: 10690141

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg i.v.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline 2 ml i.v. (Control)
Number of subjects: 90
Study: 8542136

Group type: EXPERIMENTAL
Intervention: Hyaluronan (HA) for 6 months
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo treatment for 6 months
Number of subjects: 29
Study: 1450310

Group type: COMPARATOR
Intervention: Saline (0.1 cc/kg) administered to Group 1 (G1) patients 3 minutes prior to intubation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lidocaine (1 mg/kg) administered to Group 2 (G2) patients 3 minutes prior to intubation
Number of subjects: 20
Study: 6375621

Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Imipramine hydrochloride
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30823963

Group type: EXPERIMENTAL
Intervention: Aerobic and resistance interval training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Aerobic interval training alone
Number of subjects: 26
Study: 30261986

Group type: EXPERIMENTAL
Intervention: Single educational session by a respiratory nurse specialist for about 10 minutes
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no educational session)
Number of subjects: 160
Study: 27214664

Group type: EXPERIMENTAL
Intervention: Dipraglurant (50 mg once daily)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Dipraglurant (100 mg 3 times daily)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 26037427

Group type: EXPERIMENTAL
Intervention: Protocol-based early goal-directed therapy (EGDT)
Number of subjects: 1341

Group type: EXPERIMENTAL
Intervention: Protocol-based standard therapy (ST)
Number of subjects: 1341

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1341
Study: 22786751

Group type: EXPERIMENTAL
Intervention: Zibotentan 10 mg/day
Number of subjects: 594

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 594
Study: 20142025

Group type: EXPERIMENTAL
Intervention: Perceived adverse effects (AE) such as dizziness, dry cough, nausea, diarrhea, and gout.
Number of subjects: 754

Group type: EXPERIMENTAL
Intervention: Dry cough (perceived AE).
Number of subjects: 754

Group type: EXPERIMENTAL
Intervention: Gout (perceived AE).
Number of subjects: 754
Study: 18678157

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Valpromide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Valpromide (medication group)
Number of subjects: 60
Study: 15944531

Group type: EXPERIMENTAL
Intervention: Dipyridamole-stress imaging
Number of subjects: 92

Group type: COMPARATOR
Intervention: Redistribution images
Number of subjects: 92
Study: 12463967

Group type: EXPERIMENTAL
Intervention: L-thyroxine treatment for 6 months until normalization of TSH
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 10472236

Group type: EXPERIMENTAL
Intervention: Tetracaine gel 1 g applied for 45 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: EMLA cream 2 g applied for 60 min
Number of subjects: 60
Study: 9121999

Group type: EXPERIMENTAL
Intervention: L-thyroxin treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 12
Study: 1830636

Group type: EXPERIMENTAL
Intervention: 2 mg oestradiol valerate combined with cyproterone acetate, medroxyprogesterone acetate or levonorgestrel
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: 1.5 mg 17 beta‐oestradiol combined with desogestrel
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: All hormone regimens
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Hydroxyprogesterone derivatives
Number of subjects: 148
Study: 7258218

Group type: EXPERIMENTAL
Intervention: Alcohol (2 ml/kg of body weight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (after alcohol ingestion)
Number of subjects: 20
Study: 31460835

Group type: EXPERIMENTAL
Intervention: 0.05% Chlorhexidine Gluconate (CHG)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 267
Study: 31462284

Group type: EXPERIMENTAL
Intervention: Performance-based financing and integrated care intervention
Number of subjects: 1084

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 1084
Study: 28364685

Group type: EXPERIMENTAL
Intervention: One-to-one peer support delivered by trained peers over six months
Number of subjects: 216

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 216
Study: 26991724

Group type: EXPERIMENTAL
Intervention: Daily isometric hand grip exercises before chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine activities only (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily isometric hand grip exercises
Number of subjects: 0
Study: 24692089

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 19481

Group type: COMPARATOR
Intervention: Open surgery (OP)
Number of subjects: 19481
Study: 22116959

Group type: EXPERIMENTAL
Intervention: Multifocal VEP amplitudes
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard perimetry
Number of subjects: 58
Study: 21179730

Group type: EXPERIMENTAL
Intervention: Jiaji (EX-B2) needling
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham-acupuncture (Control)
Number of subjects: 62
Study: 17666281

Group type: EXPERIMENTAL
Intervention: Immediate treatment with plasma
Number of subjects: 0
Study: 16241020

Group type: EXPERIMENTAL
Intervention: Bupivacaine with fentanyl (BF)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Bupivacaine with morphine (BM)
Number of subjects: 90
Study: 12045581

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg intravenously)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 9455794

Group type: COMPARATOR
Intervention: Beta-carotene 30 mg/day
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Retinol 25,000 IU/day
Number of subjects: 1024
Study: 7649718

Group type: EXPERIMENTAL
Intervention: Methylphenidate (30 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Desipramine (150 mg daily)
Number of subjects: 20
Study: 2573312

Group type: EXPERIMENTAL
Intervention: Beta 2 adrenergic agonists (fenoterol, salbutamol, terbutaline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Storage of whole blood at 4 degrees C
Number of subjects: 0
Study: 29168016

Group type: EXPERIMENTAL
Intervention: Peer Navigator Program (PNP)
Number of subjects: 20
Study: 28850726

Group type: EXPERIMENTAL
Intervention: Self-compassion course (2 weeks)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 158
Study: 26297089

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study: 23363007

Group type: EXPERIMENTAL
Intervention: Internet-based treatment program for female sexual dysfunction
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control participants who elected to enter treatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall attrition reasons
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Relationship satisfaction and intimacy levels
Number of subjects: 40
Study: 21946316

Group type: EXPERIMENTAL
Intervention: Right Atrial Appendage (RAA) pacing
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Low Interatrial Septum (IAS) pacing
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (ΔCTos < 50 ms)
Number of subjects: 102
Study: 18842166

Group type: EXPERIMENTAL
Intervention: ezetimibe + simvastatin
Number of subjects: 109

Group type: COMPARATOR
Intervention: simvastatin + placebo
Number of subjects: 109
Study: 16740317

Group type: EXPERIMENTAL
Intervention: Sudarshana Kriya Yoga (SKY) therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no SKY therapy)
Number of subjects: 60
Study: 14662525

Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia (TEA) with general anesthesia
Number of subjects: 73

Group type: COMPARATOR
Intervention: General anesthesia only
Number of subjects: 73
Study: 11041775

Group type: EXPERIMENTAL
Intervention: Pilocarpine hydrochloride (Salagen) 15 mg per day with a 5 mg optional increase at 5 weeks up to a daily dose of 25 mg beyond 9 weeks
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Pilocarpine hydrochloride
Number of subjects: 156
Study: 8993757

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) plus HIV-1-specific transfer factor (TF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Zidovudine (ZDV)
Number of subjects: 20
Study: 1729060

Group type: EXPERIMENTAL
Intervention: Standard histamine protocol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Abbreviated histamine protocol (30 s interval)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Abbreviated histamine protocol (3 min interval)
Number of subjects: 24
Study: 6369290

Group type: EXPERIMENTAL
Intervention: Oral disopyramide (300 mg loading dose, then 100 mg qds)
Number of subjects: 1985

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1985
Study: 31202957

Group type: EXPERIMENTAL
Intervention: Ensifentrine 0.4, 1.5, 6 and 24 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Salbutamol 2.5 and 7.5 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 30522735

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26590876

Group type: EXPERIMENTAL
Intervention: Brief Integrated Motivational Intervention (BIMI) with Treatment As Usual (TAU)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU) alone
Number of subjects: 59
Study: 25121986

Group type: EXPERIMENTAL
Intervention: internet-based problem-solving training (iPST)
Number of subjects: 150

Group type: COMPARATOR
Intervention: waitlist control group (WLC)
Number of subjects: 150
Study: 22679714

Group type: EXPERIMENTAL
Intervention: EA assistant general anesthesia (Group B)
Number of subjects: 120
Study: 20166624

Group type: EXPERIMENTAL
Intervention: 0.5% morphine drops
Number of subjects: 40

Group type: COMPARATOR
Intervention: vehicle control
Number of subjects: 40
Study: 17978611

Group type: EXPERIMENTAL
Intervention: Endotracheal tube with subglottic secretion aspiration port
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard endotracheal tube (implied control)
Number of subjects: 0
Study: 15570319

Group type: EXPERIMENTAL
Intervention: Phosphorus supplement (taken three times a day for 2 weeks)
Number of subjects: 7

Group type: COMPARATOR
Intervention: No phosphorus supplement (4th week)
Number of subjects: 7
Study: 12153667

Group type: EXPERIMENTAL
Intervention: Therapeutic cerclage and bed rest
Number of subjects: 35

Group type: COMPARATOR
Intervention: Bed rest only
Number of subjects: 35
Study: 9873346

Group type: EXPERIMENTAL
Intervention: Hand-held Doppler
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard insertion technique
Number of subjects: 0
Study: 7784717

Group type: EXPERIMENTAL
Intervention: 300 mg of SRT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 400 mg of SRT
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 500 mg of SRT
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2150795

Group type: EXPERIMENTAL
Intervention: 2 mg cyproterone acetate (CPA) + 0.035 mg ethinyl estradiol (EE2) (Diane ‐35)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 mg cyproterone acetate (CPA) + 0.050 mg ethinyl estradiol (EE2) (Diane ‐50)
Number of subjects: 0
Study: 629924

Group type: EXPERIMENTAL
Intervention: Modified fat-high-carbohydrate diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard low-carbohydrate diet
Number of subjects: 0
Study: 31905615

Group type: EXPERIMENTAL
Intervention: Quercetin-rich onion powder (9 g per day for 12 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 28111110

Group type: EXPERIMENTAL
Intervention: Smartphone-based asthma action plans (AAPs)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Paper-based asthma action plans (AAPs)
Number of subjects: 34
Study: 26591854

Group type: EXPERIMENTAL
Intervention: Laparoscopic plication of gastric big curvature (LP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 0
Study: 22459389

Group type: EXPERIMENTAL
Intervention: log-CRP
Number of subjects: 2273

Group type: EXPERIMENTAL
Intervention: log-suPAR
Number of subjects: 2273
Study: 22000449

Group type: EXPERIMENTAL
Intervention: PSA nerve blocks
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Buccal infiltrations
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Buccal plus palatal infiltrations
Number of subjects: 94
Study: 18471628

Group type: EXPERIMENTAL
Intervention: Cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and posterior optic buttonholing (POBH) of the IOL
Number of subjects: 23

Group type: COMPARATOR
Intervention: Conventional phacoemulsification cataract surgery with in-the-bag IOL implantation
Number of subjects: 23
Study: 16320174

Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (12 g CHO kgbm (‐1) . day (‐1))
Number of subjects: 32

Group type: COMPARATOR
Intervention: Self-selected diet (SS)
Number of subjects: 32
Study: 12007668

Group type: EXPERIMENTAL
Intervention: Rapid titration regimen (150 mg/day reached at day five)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Slow titration regimen (150 mg/day reached at day 15)
Number of subjects: 32
Study: 10477776

Group type: EXPERIMENTAL
Intervention: Growth hormone (mean daily dose, 0.10 +/- 0.02 mg/kg)
Number of subjects: 532

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study: 7818000

Group type: EXPERIMENTAL
Intervention: Duodenum-preserving pancreatic head resection (DPPHR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pylorus-preserving Whipple (PPW)
Number of subjects: 40
Study: 10103699

Group type: EXPERIMENTAL
Intervention: Heparin 10 units/mL flushing solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline flushing solution
Number of subjects: 0
Study: 347465

Group type: EXPERIMENTAL
Intervention: Maprotiline (oral dose of 75 or 150 mg per day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 0
Study: 31511057

Group type: EXPERIMENTAL
Intervention: Implantable Cardiac Monitor (ICM)
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1400
Study: 28711468

Group type: EXPERIMENTAL
Intervention: CGM plus CSII
Number of subjects: 75

Group type: COMPARATOR
Intervention: CGM plus MDI
Number of subjects: 75
Study: 25773819

Group type: EXPERIMENTAL
Intervention: 3D‐CRT plus tamoxifen (60 mg/m2/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3D‐CRT plus temozolomide (75 mg/m2/d)
Number of subjects: 60
Study: 23642375

Group type: EXPERIMENTAL
Intervention: Oral omega-3 (180 mg EPA and 120 mg DHA, 2 capsules daily for 30 days)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (2 medium-chain triglyceride oil capsules daily for 1 month)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Oral omega-3
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 21285968

Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 19253803

Group type: EXPERIMENTAL
Intervention: Rehabilitation Swallowing Therapy (RST)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Neuromuscular Electrical Stimulation Therapy (NMES)
Number of subjects: 23
Study: 17049890

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 93

Group type: COMPARATOR
Intervention: Valproic acid
Number of subjects: 93

Group type: COMPARATOR
Intervention: St. John's wort
Number of subjects: 93
Study: 15495489

Group type: EXPERIMENTAL
Intervention: Creative arts intervention (CAI)
Number of subjects: 40
Study: 11568194

Group type: EXPERIMENTAL
Intervention: Double-stranded semitendinosus-gracilis graft with a two-incision technique (group I)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Patellar ligament graft with a two-incision technique (group II)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Patellar ligament graft with a single-incision endoscopic technique (group III)
Number of subjects: 225

Group type: COMPARATOR
Intervention: All groups (I, II, III)
Number of subjects: 225
Study: 9804602

Group type: COMPARATOR
Intervention: Water placebo (WP)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hypotonic 6% carbohydrate beverage (197 mosmol/kgH2O)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Isotonic 6% carbohydrate beverage (295 mosmol/kgH2O)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Hypertonic 6% carbohydrate beverage (414 mosmol/kgH2O)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: All beverages (WP, hypo-, iso-, and hypertonic solutions)
Number of subjects: 7
Study: 7920495

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (group R)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Standard care (group H)
Number of subjects: 125
Study: 3408211

Group type: EXPERIMENTAL
Intervention: Special intervention (aggressive risk factor management)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 31605405

Group type: EXPERIMENTAL
Intervention: 6-mm-short implants
Number of subjects: 30

Group type: COMPARATOR
Intervention: 11-mm-long implants
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 29389758

Group type: EXPERIMENTAL
Intervention: Dithiothreitol (DTT)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Sonication
Number of subjects: 232
Study: 28356089

Group type: EXPERIMENTAL
Intervention: Sedentary behaviour patterns (sedentary time, sedentary bouts, sedentary breaks)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Light physical activity (LPA) participation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Moderate-to-vigorous physical activity (MVPA) engagement
Number of subjects: 61
Study: 26126565

Group type: EXPERIMENTAL
Intervention: Care Navigation (CN)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 500